ARV-1003

About Pinion Immunotherapeutics

Pinion Immunotherapeutics is a privately held, preclinical-stage biotech leveraging an integrated AI and mRNA/LNP platform to create immunotherapies for viral diseases and cancers. Founded in 2021 and operating as a lean, virtual company, it focuses on capital-efficient development of treatments for large markets lacking curative options. Its leadership team combines deep expertise in vaccine development, immunology, and clinical oncology, aiming to achieve functional cures through dual immune activation.

Therapeutic Areas